NCT06917560View on ClinicalTrials.gov

Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study

Active, not recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2027

Conditions
Renal CarcinomaSerologyAutoantibody
Trial Locations (1)

350005

first hospital affiliated of Fujian medical university, Fuzhou

All Listed Sponsors
collaborator

China-Japan Friendship Hospital

OTHER

collaborator

The First Affiliated Hospital of Xiamen University

OTHER

lead

First Affiliated Hospital of Fujian Medical University

OTHER

NCT06917560 - Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study | Biotech Hunter | Biotech Hunter